bimagrumab + semaglutide A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass – suggesting a promising approach for BELIEVE: Bimagrumab/Semaglutide Combo Yields Substantial

do not stop the medication without medical advice as this may affect diabetes control

Cureus, 15(2).

Bodhinathan K, Kumar A, Foster C

Patients should contact their GP if they experience: Persistent vomiting or diarrhoea leading to dehydration Severe abdominal pain Signs of allergic reaction (rash, difficulty breathing, facial swelling) Symptoms of pancreatitis or gallbladder disease Changes in vision Pregnancy should be avoided during treatment, and semaglutide should be discontinued at least two months before planned conception due to limited safety data

The anti-hypersensitive effects were completely prevented by GLP-1R antagonism and GLP-1R gene knockdown [24]